The 2008 American College of Rheumatology recommendations for the Use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis: Where the rubber meets the road

Arthritis Care and Research

Volumn 59, Issue 6, 2008, Pages 757-759

  Bathon, Joan M ^a   Cohen, Stanley B ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; DISEASE MODIFYING ANTIRHEUMATIC DRUG; IMMUNOLOGIC AGENT; METHOTREXATE; RITUXIMAB; TUMOR NECROSIS FACTOR INHIBITOR;

BIOLOGICAL THERAPY; COMORBIDITY; DISEASE ACTIVITY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EDITORIAL; EVIDENCE BASED MEDICINE; HEALTH CARE COST; HEALTH CARE SYSTEM; HUMAN; MEDICAL DECISION MAKING; PATIENT MONITORING; PRACTICE GUIDELINE; PREGNANCY; PROGNOSIS; RHEUMATOID ARTHRITIS; RISK BENEFIT ANALYSIS; TREATMENT OUTCOME;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BIOLOGICAL PRODUCTS; GUIDELINES AS TOPIC; HUMANS; RHEUMATOLOGY; SOCIETIES, MEDICAL; UNITED STATES;

EID: 45349095153     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.23723     Document Type: Editorial

References (4)

1. American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis: 2002 update. Arthritis Rheum 2002;46:328-46.
2. Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, Curtis JR, et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic in rheumatoid arthritis. Arthritis Rheum 2008;59:762-84.
3. O'Dell JR. It is the best of times; it is the worst of times: is there a way forward? A plethora of treatment options for rheumatoid arthritis, but critical trial design issues [editorial]. Arthritis Rheum 2007;56:3884-6.
4. Wiles NJ, Lunt M, Barrett EM, Bukhari M, Silman AJ, Symmons DP, et al. Reduced disability at five years with early treatment of inflammatory polyarthritis: results from a large observational cohort, using propensity models to adjust for disease severity. Arthritis Rheum 2001;44:1033-42.